About Derma Sciences
Derma Sciences is a Technology company based in Princeton (United States) founded in 1984, and was acquired by Integra LifeSciences in January 2017. Developer of tissue regeneration and wound care products. It operates in the Technology, Aerospace, Defense & Maritime, and Healthcare sectors. Derma Sciences has raised $16.16 million across 9 funding rounds from investors including Integra LifeSciences and HHS. The company has 123 employees. Derma Sciences has completed 1 acquisition, including BioD. Its focus areas include Aerospace, Maritime and Defense Tech, Military Tech, Healthcare Solutions and Therapeutic Devices. Its legal entity is DERMA SCIENCES, INC. Its competitors include Imbed Biosciences, Ensoma and Tenaya Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
The company was founded in 1984 and is headquartered in Princeton, United States. Focus is placed on the healthcare sector, specifically tissue regeneration and wound care. Operations are structured into three segments: pharmaceutical wound care, advanced wound care, and traditional wound care products. These segments support the development and distribution of related medical solutions for various applications.
- Headquarters Princeton, United States
- Employees 123
- Stage Acquired
- SectorsTechnologyAerospace, Defense & Maritime Healthcare
- Email••••••••
- Website dermasciences.com
- Social LinkedIn X
- Acquired by Integra LifeSciences (Jan 2017)
- Legal Name Derma Sciences, Inc.
- Total Equity Funding$16.16M (USD)
in 9 rounds
- Latest Funding Round$29.07M (USD), Post-IPO
Jul 2011
- InvestorsIntegra LifeSciences
& 1 more
- Employee Count123
- Investments & Acquisitions
- Acquired byIntegra LifeSciences
(Jan 2017)
Funding Insights of Derma Sciences
Derma Sciences has successfully raised a total of $16.16M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $29.07 million completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.16M
- Total Rounds 9
- Last Round Post-IPO — $29.07M
- First Round $650,000
(Jun 2002)
- Investors Count 1
All 9 funding rounds of Derma Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2011 | $29.07M | Post-IPO | – | – | – |
| Feb 2011 | $4.5M | Grant | – | – | |
| Apr 2008 | $6.1M | Post-IPO | – | – | – |
| Nov 2007 | $6M | Series B | – | – | – |
| Aug 2006 | $1.5M | Series A | – | – | – |
| Apr 2006 | $6.5M | Series A | – | – | – |
| Mar 2004 | $2.16M | Series A | – | – | – |
| Jun 2003 | $1.35M | Unspecified | – | – | – |
| Jun 2002 | $650,000 | Unspecified | – | – | – |
2 investors in total: 2 institutional.
Investors in Derma Sciences
Derma Sciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Integra LifeSciences and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Diversified medical devices are developed for healthcare applications. | 1989 | integralife.com | Plainsboro, United States |
Investor details for Derma Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Derma Sciences
9 people are tracked at Derma Sciences (5 in leadership, 4 in team); the tracked headcount is 123.
| Name | Role | Group |
|---|---|---|
Jodie Currie | Director, Corporate Accounts | Leadership |
Jan De Witte | CEO | Leadership |
Derma Sciences | Ceo | Leadership |
Muhammad Haseeb | Chief Executive Officer | Leadership |
Randi Rutan | Vice President, Medical Affairs | Leadership |
Christine Flynn | Sales Operations Manager | Team |
Sandy Venere | Executive Assistant | Team |
Patrick McLaughlin | Advanced Wound Care Product Specialist | Team |
Karen Jones | Account Executive Wound Care | Team |
Complete people profiles for Derma Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Derma Sciences
Derma Sciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BioD.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Novel biologic products from placental tissues are developed and commercialized. | biodlogics.com | Memphis, United States | 2010 | Jul 2016 | $21.3M |
Complete acquisition details for Derma Sciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Derma Sciences
6 dated milestones of Derma Sciences across 33 years, from founding to its latest funding, stage changes and deals.
- Founded Derma Sciences is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $650K.
- Funding Latest funding round, Post-IPO, of $29.1M.
- Acquisition Acquires BioD.
- Exit Acquired by Integra LifeSciences.
Competitors of Derma Sciences
Derma Sciences has 3 listed competitors in our database, 3 of them funded. They include Imbed Biosciences, Ensoma and Tenaya Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imbedbio.com | 2010 | Madison, United States | $22.7M | 35 | Nanotech-based wound care products are developed and provided. | |
| ensoma.com | 2019 | Boston, United States | $205M | 52 | Provider of in vivo stem cell modification technologies and vector-based drug delivery tool | |
| tenayatherapeutics.com | 2016 | San Francisco, United States | $142M | 140 | Regenerative and gene therapeutics for heart failure are developed. |
Detailed competitors of Derma Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Derma Sciences
Websites that share an audience with Derma Sciences (dermasciences.com).
Websites whose visitors overlap most with Derma Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
umf.org.nz | umf.org.nz | 100% | #1,655,977 | – | |
dumex.com | dumex.com | 99% | – | ||
woundcareshop.com | woundcareshop.com | 97% | #6,588,498 | – | |
| exactsciences.com | 95% | 546.4K | #82,917 | View details | |
| deroyal.com | 94% | #1,331,533 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Derma Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nanotechnology
3 companies that operate in the same segment as Derma Sciences (Nanotechnology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Derma Sciences
Complete news archive for Derma Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Derma Sciences
Derma Sciences was founded in 1984 and raised its 1st funding round 18 years after it was founded.
Derma Sciences is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Derma Sciences is a funded company, having raised a total of $16.16M across 9 funding rounds to date. The company's 1st funding round was a Unspecified of $650K, raised on Jun 2002.
Derma Sciences has 123 employees.
The company was founded in 1984 and is headquartered in Princeton, United States. Focus is placed on the healthcare sector, specifically tissue regeneration and wound care. Operations are structured into three segments: pharmaceutical wound care, advanced wound care, and traditional wound care products. These segments support the development and distribution of related medical solutions for various applications.
Derma Sciences's top competitors include Imbed Biosciences, Tenaya Therapeutics and Ensoma.
Derma Sciences has made 1 acquisition, including BioD.
Derma Sciences has 2 investors. Key investors include Integra LifeSciences, and HHS.
Derma Sciences operates through Derma Sciences, Inc..
Yes. Derma Sciences was acquired by Integra LifeSciences in January 2017.